• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用机器学习诊断和预测阿尔茨海默病的脂蛋白和代谢物。

Lipoproteins and metabolites in diagnosing and predicting Alzheimer's disease using machine learning.

机构信息

Department of Health Statistics, School of Public Health, Shandong Second Medical University, Weifang, Shandong, 261053, China.

Department of Rheumatology and Immunology, Affiliated Hospital of Shandong Second Medical University, Weifang, Shandong, 261031, China.

出版信息

Lipids Health Dis. 2024 May 21;23(1):152. doi: 10.1186/s12944-024-02141-w.

DOI:10.1186/s12944-024-02141-w
PMID:38773573
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11107010/
Abstract

BACKGROUND

Alzheimer's disease (AD) is a chronic neurodegenerative disorder that poses a substantial economic burden. The Random forest algorithm is effective in predicting AD; however, the key factors influencing AD onset remain unclear. This study aimed to analyze the key lipoprotein and metabolite factors influencing AD onset using machine-learning methods. It provides new insights for researchers and medical personnel to understand AD and provides a reference for the early diagnosis, treatment, and early prevention of AD.

METHODS

A total of 603 participants, including controls and patients with AD with complete lipoprotein and metabolite data from the Alzheimer's disease Neuroimaging Initiative (ADNI) database between 2005 and 2016, were enrolled. Random forest, Lasso regression, and CatBoost algorithms were employed to rank and filter 213 lipoprotein and metabolite variables. Variables with consistently high importance rankings from any two methods were incorporated into the models. Finally, the variables selected from the three methods, with the participants' age, sex, and marital status, were used to construct a random forest predictive model.

RESULTS

Fourteen lipoprotein and metabolite variables were screened using the three methods, and 17 variables were included in the AD prediction model based on age, sex, and marital status of the participants. The optimal random forest modeling was constructed with "mtry" set to 3 and "ntree" set to 300. The model exhibited an accuracy of 71.01%, a sensitivity of 79.59%, a specificity of 65.28%, and an AUC (95%CI) of 0.724 (0.645-0.804). When Mean Decrease Accuracy and Gini were used to rank the proteins, age, phospholipids to total lipids ratio in intermediate-density lipoproteins (IDL_PL_PCT), and creatinine were among the top five variables.

CONCLUSIONS

Age, IDL_PL_PCT, and creatinine levels play crucial roles in AD onset. Regular monitoring of lipoproteins and their metabolites in older individuals is significant for early AD diagnosis and prevention.

摘要

背景

阿尔茨海默病(AD)是一种慢性神经退行性疾病,给经济带来了巨大的负担。随机森林算法在预测 AD 方面非常有效,但影响 AD 发病的关键因素仍不清楚。本研究旨在通过机器学习方法分析影响 AD 发病的关键脂蛋白和代谢物因素。为研究人员和医务人员了解 AD 提供了新的视角,并为 AD 的早期诊断、治疗和早期预防提供了参考。

方法

本研究共纳入了 603 名参与者,包括来自 2005 年至 2016 年 ADNI 数据库的对照组和 AD 患者,他们的脂蛋白和代谢物数据完整。采用随机森林、Lasso 回归和 CatBoost 算法对 213 个脂蛋白和代谢物变量进行排序和筛选。将两种方法的重要性排名始终较高的变量纳入模型。最后,将三种方法中筛选出的变量与参与者的年龄、性别和婚姻状况一起,构建随机森林预测模型。

结果

采用三种方法筛选出 14 个脂蛋白和代谢物变量,根据参与者的年龄、性别和婚姻状况,共纳入 17 个变量建立 AD 预测模型。最优随机森林模型的“mtry”设置为 3,“ntree”设置为 300。该模型的准确率为 71.01%,敏感度为 79.59%,特异性为 65.28%,AUC(95%CI)为 0.724(0.645-0.804)。当使用平均减少准确性和基尼系数对蛋白质进行排序时,年龄、中间密度脂蛋白(IDL)中的磷脂与总脂质的比例(IDL_PL_PCT)和肌酐位于前 5 位。

结论

年龄、IDL_PL_PCT 和肌酐水平在 AD 发病中起着关键作用。定期监测老年人的脂蛋白及其代谢物对 AD 的早期诊断和预防具有重要意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dae/11107010/6d9f9109a261/12944_2024_2141_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dae/11107010/25d81d761d89/12944_2024_2141_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dae/11107010/a1c3f350e810/12944_2024_2141_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dae/11107010/5f09a7a00615/12944_2024_2141_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dae/11107010/21b3d0b96874/12944_2024_2141_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dae/11107010/6d9f9109a261/12944_2024_2141_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dae/11107010/25d81d761d89/12944_2024_2141_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dae/11107010/a1c3f350e810/12944_2024_2141_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dae/11107010/5f09a7a00615/12944_2024_2141_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dae/11107010/21b3d0b96874/12944_2024_2141_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dae/11107010/6d9f9109a261/12944_2024_2141_Fig5_HTML.jpg

相似文献

1
Lipoproteins and metabolites in diagnosing and predicting Alzheimer's disease using machine learning.使用机器学习诊断和预测阿尔茨海默病的脂蛋白和代谢物。
Lipids Health Dis. 2024 May 21;23(1):152. doi: 10.1186/s12944-024-02141-w.
2
A Machine Learning-Based Holistic Approach to Predict the Clinical Course of Patients within the Alzheimer's Disease Spectrum.基于机器学习的阿尔茨海默病谱患者临床病程预测的整体方法。
J Alzheimers Dis. 2022;85(4):1639-1655. doi: 10.3233/JAD-210573.
3
Plasma d-glutamate levels for detecting mild cognitive impairment and Alzheimer's disease: Machine learning approaches.血浆谷氨酸水平检测轻度认知障碍和阿尔茨海默病:机器学习方法。
J Psychopharmacol. 2021 Mar;35(3):265-272. doi: 10.1177/0269881120972331. Epub 2021 Feb 15.
4
A blood-based screening tool for Alzheimer's disease that spans serum and plasma: findings from TARC and ADNI.用于阿尔茨海默病的基于血液的筛查工具,涵盖血清和血浆:来自 TARC 和 ADNI 的研究结果。
PLoS One. 2011;6(12):e28092. doi: 10.1371/journal.pone.0028092. Epub 2011 Dec 7.
5
Optimizing Machine Learning Methods to Improve Predictive Models of Alzheimer's Disease.优化机器学习方法以提高阿尔茨海默病预测模型的性能。
J Alzheimers Dis. 2019;71(3):1027-1036. doi: 10.3233/JAD-190262.
6
Comparing different algorithms for the course of Alzheimer's disease using machine learning.使用机器学习比较阿尔茨海默病病程的不同算法。
Ann Palliat Med. 2021 Sep;10(9):9715-9724. doi: 10.21037/apm-21-2013.
7
Predicting Alzheimer's Disease with Interpretable Machine Learning.使用可解释的机器学习预测阿尔茨海默病。
Dement Geriatr Cogn Disord. 2023;52(4):249-257. doi: 10.1159/000531819. Epub 2023 Jul 21.
8
Machine Learning and Novel Biomarkers for the Diagnosis of Alzheimer's Disease.机器学习与新型生物标志物在阿尔茨海默病诊断中的应用。
Int J Mol Sci. 2021 Mar 9;22(5):2761. doi: 10.3390/ijms22052761.
9
hdWGCNA and Cellular Communication Identify Active NK Cell Subtypes in Alzheimer's Disease and Screen for Diagnostic Markers through Machine Learning.hdWGCNA 和细胞通讯通过机器学习鉴定阿尔茨海默病中活跃的 NK 细胞亚型并筛选诊断标志物。
Curr Alzheimer Res. 2024;21(2):120-140. doi: 10.2174/0115672050314171240527064514.
10
ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease.载脂蛋白E4对轻度认知障碍和阿尔茨海默病自动诊断分类器的影响。
Neuroimage Clin. 2014 Jan 4;4:461-72. doi: 10.1016/j.nicl.2013.12.012. eCollection 2014.

引用本文的文献

1
Clinical prediction models using artificial intelligence approaches in dementia.使用人工智能方法的痴呆症临床预测模型。
Aging Clin Exp Res. 2025 Jul 25;37(1):233. doi: 10.1007/s40520-025-03112-6.
2
Lipid trajectories improve risk models for Alzheimer's disease and mild cognitive impairment.脂质轨迹改善了阿尔茨海默病和轻度认知障碍的风险模型。
J Lipid Res. 2025 Jan;66(1):100714. doi: 10.1016/j.jlr.2024.100714. Epub 2024 Nov 23.

本文引用的文献

1
Alzheimer's Disease in Diabetic Patients: A Lipidomic Prospect.糖尿病患者的阿尔茨海默病:脂质组学展望。
Neuroscience. 2023 Oct 15;530:79-94. doi: 10.1016/j.neuroscience.2023.08.033. Epub 2023 Aug 29.
2
Metabolomic Footprint of Disrupted Energetics and Amino Acid Metabolism in Neurodegenerative Diseases: Perspectives for Early Diagnosis and Monitoring of Therapy.神经退行性疾病中能量代谢和氨基酸代谢紊乱的代谢组学特征:早期诊断和治疗监测的前景
Metabolites. 2023 Mar 1;13(3):369. doi: 10.3390/metabo13030369.
3
Lipoprotein Metabolism, Protein Aggregation, and Alzheimer's Disease: A Literature Review.
脂蛋白代谢、蛋白质聚集与阿尔茨海默病:文献综述
Int J Mol Sci. 2023 Feb 2;24(3):2944. doi: 10.3390/ijms24032944.
4
Pathogenesis of Alzheimer's Disease.阿尔茨海默病的发病机制。
Int J Mol Sci. 2022 Dec 21;24(1):107. doi: 10.3390/ijms24010107.
5
Prediction of Mefenamic Acid Crystal Shape by Random Forest Classification.基于随机森林分类法预测甲芬那酸晶体形态。
Pharm Res. 2022 Dec;39(12):3099-3111. doi: 10.1007/s11095-022-03450-4. Epub 2022 Dec 19.
6
Spontaneous speech feature analysis for alzheimer's disease screening using a random forest classifier.使用随机森林分类器进行阿尔茨海默病筛查的自发语音特征分析
Front Digit Health. 2022 Nov 17;4:901419. doi: 10.3389/fdgth.2022.901419. eCollection 2022.
7
Alzheimer's Disease and Inflammaging.阿尔茨海默病与炎症衰老
Brain Sci. 2022 Sep 13;12(9):1237. doi: 10.3390/brainsci12091237.
8
A Joint Model of Random Forest and Artificial Neural Network for the Diagnosis of Endometriosis.一种用于子宫内膜异位症诊断的随机森林与人工神经网络联合模型
Front Genet. 2022 Mar 8;13:848116. doi: 10.3389/fgene.2022.848116. eCollection 2022.
9
Chronological Age Prediction: Developmental Evaluation of DNA Methylation-Based Machine Learning Models.年龄预测:基于DNA甲基化的机器学习模型的发育评估
Front Bioeng Biotechnol. 2022 Jan 24;9:819991. doi: 10.3389/fbioe.2021.819991. eCollection 2021.
10
Challenges and hopes for Alzheimer's disease.阿尔茨海默病的挑战与希望。
Drug Discov Today. 2022 Apr;27(4):1027-1043. doi: 10.1016/j.drudis.2022.01.016. Epub 2022 Feb 1.